Tech-based Respite Care for Caregivers and Homebound Older Adults
TechRespiteRCT
1 other identifier
interventional
180
1 country
1
Brief Summary
The goal of this study is to examine the effectiveness of VR-based respite in improving cognitive function, mental health, and quality of life in caregivers and homebound older adults compared to a control group using videos and a usual care group. Participants are randomly assigned to one of three groups: VR intervention, video control, or usual care. The VR group receives immersive VR sessions using the SilVR Adventures platform. The video group receives non-immersive video sessions with similar content. The usual care group receives no additional intervention. Assessments are conducted at baseline, immediate post-intervention, and 3 months post-intervention to measure changes in depression, anxiety, loneliness, quality of life, and other outcomes. The intervention dosage will be 4 weeks (1 sessions/week; 30 min/session). Secondarily, the study explores differences in effectiveness between caregivers and homebound older adults, and potential moderators or mediators such as baseline health status, technological literacy, and social support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
September 12, 2025
August 1, 2025
1.2 years
August 29, 2025
September 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change from baseline in depression and anxiety on PHQ-4 after intervention
The Patient Health Questionnaire-4 (PHQ-4) is a validated 4-item scale measuring depression and anxiety over the past two weeks. Rated on a 4-point scale from "not at all" to "nearly every day." Change = (Immediate after intervention - baseline) and (3 months after intervention - baseline)
Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in quality of life on EQ-5D-5L after intervention
EQ-5D-5L is a validated 6-item scale measuring quality of life across 5 dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) plus a visual analogue scale (EQ-VAS, 0-100). Higher scores indicate better quality of life. Change = (Immediate after intervention - baseline) and (3 months after intervention - baseline)
Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in loneliness on UCLA Loneliness Scale after intervention
The 3-item UCLA Loneliness Scale is a validated tool measuring feelings of loneliness and social isolation. The total score can range from 3 to 9. Higher scores indicate greater degrees of loneliness. Change = (Immediate after intervention - baseline) and (3 months after intervention - baseline)
Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in subjective happiness on Subjective Happiness Scale after intervention
The Subjective Happiness Scale is a validated 4-item scale measuring global subjective happiness on a 7-point Likert scale. Reverse the score for Item 4. Calculate the mean of all four item scores (the three regular scores plus the reversed score from Item 4). The total score ranges from 1 to 7. Higher scores indicate greater subjective happiness. Change = (Immediate after intervention - baseline) and (3 months after intervention - baseline)
Baseline, Immediate after intervention, and 3 months after intervention
Secondary Outcomes (5)
Change from baseline in cognitive function on MMSE after intervention (For CRs only)
: Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in role captivity on Pearlin's model after intervention(For CGs only)
Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in technology acceptance on STAM after intervention
Baseline and Immediate after intervention
4. Change from baseline in quality of life on OPQOL-brief after intervention (For CRs only)
Baseline, Immediate after intervention, and 3 months after intervention
Change from baseline in caregiving burden on CZBI-short after intervention (For CGs only)
Baseline, Immediate after intervention, and 3 months after intervention
Study Arms (3)
VR Intervention Group
EXPERIMENTALCaregivers and homebound older adults will receive 4 weeks of VR-based respite sessions.
Video Control Group
ACTIVE COMPARATORCaregivers and homebound older adults will receive 4 weeks of video-based respite sessions.
Usual Care Group
NO INTERVENTIONCaregivers and homebound older adults will receive no additional intervention.
Interventions
Caregivers and homebound older adults will receive 4 weeks of VR-based respite sessions. 4 weeks (1 session/week; 30 min/session) of immersive VR sessions using SilVR Adventures platform. Sessions include virtual travel destinations (e.g., cities, natural wonders) and social activities (e.g., group tours). Facilitated by trained research staff, with 5-10 minutes viewing and 20 minutes reflection/discussion.
Caregivers and homebound older adults will receive 4 weeks of video-based respite sessions. 4 weeks (1 session/week; 30 min/session) of non-immersive video sessions with content similar to VR themes (e.g., landscapes, cultural events). Facilitated by trained research staff, with post-video discussion. EEG data collected during viewing to assess emotional states.
Eligibility Criteria
You may qualify if:
- Aged 18 or above
- Provide care to at least one homebound older adult (aged 60 or above)
- Provide no less than 6 hours of caregiving per week
- Able to communicate in either Cantonese, Mandarin or English
- Willing to participate for the entire duration
- Able to tolerate VR headset for at least 5 minutes (no severe motion sickness/epilepsy)
You may not qualify if:
- History of severe psychiatric disorders (e.g., schizophrenia, bipolar)
- Severe cognitive impairment (MMSE \<10)
- Major neurological diseases (e.g., recent stroke, severe Parkinson's)
- Uncorrectable visual/hearing impairments affecting VR/video
- Unable to tolerate VR due to motion sickness or discomfort
- Care recipient receiving long-term care service that conflicts with study
- Care Recipients (CRs)
- Aged 60 or above
- Homebound (unable to leave home without assistance)
- Stable medical condition
- Willing to participate for the entire duration
- Able to tolerate VR headset for at least 5 minutes (no VR contraindications)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sau Po Centre on Ageing, HKU
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Professor
Study Record Dates
First Submitted
August 29, 2025
First Posted
September 8, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
September 12, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share